logo
Plus   Neg
Share
Email

Sotheby's To Return To Private Ownership; Shareholders To Receive $57/share

Sotheby's (BID) has agreed to be acquired by BidFair USA, which is owned by entrepreneur Patrick Drahi, in a deal with an enterprise value of $3.7 billion. Sotheby's shareholders will receive $57.00 per share of the company's common stock. The transaction is anticipated to close in the fourth quarter of 2019.

Patrick Drahi is a global entrepreneur with telecommunications, media and digital properties across the globe. He is the Founder, President of the Board, and controlling shareholder of Altice Europe.

Domenico De Sole, Chairman of Sotheby's Board, said, "Following a comprehensive review, the Board enthusiastically supports Drahi's offer, which delivers a significant premium to market for our shareholders. After more than 30 years as a public company, the time is right for Sotheby's to return to private ownership to continue on a path of growth and success."

Shares of Sotheby's were up more than 58% in pre-market trade on Monday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
eBay Inc. (EBAY) Wednesday reported a fourth-quarter profit that trumped Wall Street analysts' estimates, as did revenues. However, shares of the company slipped over 5% after the company issued a weak outlook for the first quarter. eBay's fourth-quarter profit dropped to $558 million or $0.69 per... Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker reported its "highest quarterly revenue ever" driven by strong demand for its iPhone 11 and 11 Pro models during the holiday season. The tech giant also issued a strong revenue outlook... New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry.
Follow RTT
>